Peter Hintze is an experienced analytical sciences/QC leader with over 22 years of industry experience. He specializes in analytical method development, transfer, qualification/validation and management of analytical testing through all stages of the product lifecycle from pre-clinical to commercial. He also has extensive experience developing and managing stability protocols, establishing reference standards, developing product specifications, conducting laboratory investigations and authoring regulatory documents. In past roles, Peter has served in various leadership roles at Elevation Oncology, AGC Biologics and Targeted Genetics contributing to 60+ clinical programs and various commercial programs, including Andexxa®, ANKTIVA®, Ixinity®,  and TEPEZZA®   . Peter received his Bachelor's degree in Chemistry from Sacramento State University and his Master's degree in Analytical Chemistry from the University of Washington.